CalciMedica, Inc. — Form SCHEDULE 13D/A
Filed August 24, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
Alafi Capital Co LLC filed an amended Schedule 13D/A regarding beneficial ownership in CalciMedica, Inc. (a $15.7M market-cap pharmaceutical company). The filing metadata shows Alafi Capital's address (505 Coast Boulevard South, Suite 307, La Jolla, CA) and the joint filing agreement; however, the specific share count, percentage ownership, acquisition date, price paid, and nature of the amendment are not disclosed in the provided excerpts. The filing was accepted on 2026-08-24.
Why this rating
Amendment to existing disclosure; no material transaction details provided. Significance limited unless ownership stake is substantial fraction of $15.7M cap.
See more from August 24, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.